HBOT Conversations:
Join us for interviews with researchers, practitioners, industry experts, and patients to share their stories, successes, and expertise relative to hyperbaric oxygen therapy
Subscribe. Join the discussion. Share the hope.
Listen to or Watch the HBOT Conversations Podcast
Listen to the HBOT Converstations podcast by downloading it from your favorite podcasting platform or scroll down and watch an episode here on the HBOT News website:
Watch the HBOT Conversations Podcast
Subscribe Now, It’s Free !
Recent HBOT News
Clinical Trial – Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study
Cerebral radiation necrosis (CRN) is a well-documented late complication of radiation therapy
for cancers, and may have a devastating effect on the patient’s quality of life (QOL).
However,CRN was once regarded as a progressive and irreversible disease, no standard therapy
has been suggested for CRN. In our clinical practice, we have used
monosialotetrahexosylganglioside (GM1)to treat CRN, and found that GM1 can successfully
reverse CRN. So we carried out this prospective study to test the efficacy of GM1 for CRN.
Clinical Trial – Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy
The purpose of this study is to evaluate motor block probability throughout time and clinical
profile when using three different doses of HLBP 0.75% (7.5, 9.37 and 11.25 mg) by a
unilateral spinal block technique.
[Dermal and inhalation poisoning. Rare guests in our intensive care units?].
Abstract: Patients with dermal and inhalation poisoning are uncommon in intensive care treatment. We describe the diagnostics and specific toxicological treatment of patients with hydrofluoric acid burns. For inhalation poisoning, we focus on smoke inhalation,...